November 5, 2025
Blog
Balancing Innovation and Risk: Navigating Insurance for Gene Editing and Gene Therapy
As gene-editing and gene-therapy technologies advance rapidly, insurers face uncharted terrain: how to insure treatments that could be revolutionary — yet carry novel risks, high costs and regulatory uncertainty. This article from One80 Intermediaries examines key challenges and strategic insights for managing risk and innovation in this space.